참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Tazofelone | HCID 68745 | — |
| 반응물 | 3,5-Di-tert-butyl-4-hydroxybenzaldehyde | HCID 73219 | — |
| 반응물 | 5-(3,5-Bis(tert-butyl)-4-hydroxyphenyl)methylene-4-thiazolidinone | HCID 130003 | — |
| 반응물 | Rhodanine | HCID 1201546 | — |
| 반응물 | 5-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-2-thioxo-4-thiazolidinone | HCID 3071511 | — |
| 반응물 | 5-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-2-thioxo-4-thiazolidinone | HCID 9968356 | — |
| 용매 | Acetic Acid | HCID 176 | — |
| 생성물 | 5-[[3,5-Bis(1-methylethyl)-4-hydroxyphenyl]methylene]-3-methyl-4-thiazolidinone | HCID 54078454 | — |
반응 단계
The aryl-substituted rhodanine derivatives of formula I are either known in the art or may be prepared by any of a number of well-known procedures. For example, Teuber et al., Leibigs Ann. Chem., 757 (1978) disclose 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-2-thioxo-4-thiazolidinone (referred to in the following discussion as Compound A). The compound is prepared by reacting 3,5-di-tert-butyl-4-hydroxybenzaldehyde with rhodanine at reflux temperature in glacial acetic acid using fused sodium acetate as catalyst. 5-[[3,5-Bis(1,1-dimethylethyl) -4-hydroxyphenyl]methylene]-4-thiazolidinone (Compound B), 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-4-thiazolidinone (Compound C) and 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-2-thioxo -4-thiazolidinone (Compound D) can be prepared from Compound A as follows.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05731336 |
|---|
| 출처 데이터셋 | uspto-grants-1998_03 |
|---|
| ORD ID | ord-f5393e1cc6454a74b09650aa083904a0 |
|---|
| 출처 메모 | uspto-grants-1998_03 |
|---|